Inhibition of STAT3 signaling as critical molecular event in HUC-MSCs suppressed Glioblastoma Cells

Wang, Mingming; Zhang, Yufu; Liu, Min; Jia, Yuna; He, Jing; Xu, Xiangrong; Shi, Haiyan; Zhang, Yunqing; Zhang, Jing; Liu, Yusi

doi:10.7150/jca.77905



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2023; 14(4):611-627. doi:10.7150/jca.77905 This issue Cite

Research Paper

Inhibition of STAT3 signaling as critical molecular event in HUC-MSCs suppressed Glioblastoma Cells

Mingming Wang^1#, Yufu Zhang^2#, Min Liu^3#, Yuna Jia¹, Jing He⁴, Xiangrong Xu¹, Haiyan Shi¹, Yunqing Zhang^4✉, Jing Zhang^1✉, Yusi Liu^1✉

1. Department of Cell Biology and Genetics, Medical College of Yan'an University, Yan'an 716000, Shaanxi Province, China
2. Department of Hepatobiliary Surgery, Affiliated Hospital of Yan'an University, Yan'an 716000, Shaanxi Province, China
3. Department of Pathology, Affiliated Hospital of Yan'an University, Yan'an 716000, Shaanxi Province, China
4. Laboratory of Obstetrics and Gynecology, Affiliated Hospital of Yan'an University, Yan'an, 716000 Shaanxi Province, China
^#These authors equally contributed to the paper.

Citation:

Wang M, Zhang Y, Liu M, Jia Y, He J, Xu X, Shi H, Zhang Y, Zhang J, Liu Y. Inhibition of STAT3 signaling as critical molecular event in HUC-MSCs suppressed Glioblastoma Cells. J Cancer 2023; 14(4):611-627. doi:10.7150/jca.77905. https://www.jcancer.org/v14p0611.htm

Other styles

Abstract

Objective: We investigated the effect of human umbilical cord mesenchymal stem cells (HUC-MSCs) supernatants on proliferation, migration, invasion, and apoptosis in glioblastoma (GBM) cell lines RG-2, U251, U87-MG, and LN-428, as well as their apoptosis and autophagy-mediated through IL-6/JAK2/STAT3 signaling pathway to explore the molecular mechanisms.

Methods: In this study, RG-2, U251, U87-MG, and LN-428 cells were treated with 9 mg/ml HUC-MSCs supernatants. Their responses to HUC-MSCs supernatants treatment and the status of STAT3 signaling were analyzed by multiple experimental approaches to elucidate the importance of HUC-MSCs supernatants for GBM.

Results: The results demonstrated that after treatment with HUC-MSCs supernatants, in vitro proliferation of RG-2, U251, U87-MG, and LN-428 cells were inhibited, and their sustained growth was also blocked. RG-2, U251, and U87-MG cells showed significant S phase accumulation, while LN-428 cells were blocked in G0/G1 phase. Their migratory invasive capacities were inhibited, and their apoptosis and autophagy ratios were increased. These effects were mediated through the IL-6/JAK2/STAT3 and its downstream signaling pathway.

Conclusion: Our data showed that HUC-MSCs supernatants had anti-tumor effects on GBM cells. It inhibited the proliferation, migration, and invasion of GBM cells and promoted their apoptosis. Negative regulation of the IL-6/JAK2/STAT3 signaling pathway enhanced apoptosis and autophagy in tumor cells, thereby improving the therapeutic effect on GBM.

Keywords: human umbilical cord mesenchymal stem cell supernatant, glioblastoma, IL-6/JAK2/STAT3 signaling pathway

Citation styles

APA

Wang, M., Zhang, Y., Liu, M., Jia, Y., He, J., Xu, X., Shi, H., Zhang, Y., Zhang, J., Liu, Y. (2023). Inhibition of STAT3 signaling as critical molecular event in HUC-MSCs suppressed Glioblastoma Cells. Journal of Cancer, 14(4), 611-627. https://doi.org/10.7150/jca.77905.

ACS

Wang, M.; Zhang, Y.; Liu, M.; Jia, Y.; He, J.; Xu, X.; Shi, H.; Zhang, Y.; Zhang, J.; Liu, Y. Inhibition of STAT3 signaling as critical molecular event in HUC-MSCs suppressed Glioblastoma Cells. J. Cancer 2023, 14 (4), 611-627. DOI: 10.7150/jca.77905.

NLM

CSE

Wang M, Zhang Y, Liu M, Jia Y, He J, Xu X, Shi H, Zhang Y, Zhang J, Liu Y. 2023. Inhibition of STAT3 signaling as critical molecular event in HUC-MSCs suppressed Glioblastoma Cells. J Cancer. 14(4):611-627.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.